Spectroscopic and structural characterization of cationic N-(2-aminoethyl)aziridine-N,N′ chelate complexes of the d6-metals Rh(III) and Ir(III)

Synthesis, structural characterization, antimicrobial and cytotoxic effects of aziridine, 2-aminoethylaziridine and azirine complexes of copper(II) and palladium(II)

The synthesis, spectroscopic and X-ray structural characterization of copper(II) and palladium(II) complexes with aziridine ligands as 2-dimethylaziridine HNCH(2)CMe(2) (a), the bidentate N-(2-aminoethyl)aziridines C(2)H(4)NC(2)H(4)NH(2) (b) or CH(2)CMe(2)NCH(2)CMe(2)NH(2) (c) as well as the unsaturated azirine NCH(2)CPh (d) are reported. Cleavage of the cyclometallated Pd(II) dimer [μ-Cl(C(6)H(4)CHMeNMe(2)-C,N)Pd](2) with ligand a yielded compound [Cl(NHCH(2)CMe(2))(C(6)H(4)CHMe(2)NMe(2)-C,N)Pd] (1a). The reaction of the aziridine complex trans-[Cl(2)Pd(HNC(2)H(4))(2)] with an excess of aziridine in the presence of AgOTf gave the ionic chelate complex trans-[(C(2)H(4)NC(2)H(4)NH(2)-N,N')(2)Pd](OTf)(2) (2b) which contains the new ligand b formed by an unexpected insertion and ring opening reaction of two aziridines ("aziridine dimerization"). CuCl(2) reacted in pure HNC(2)H(4) or HNCH(2)CMe(2) (b) again by "dimerization" to give the tris-chelated ionic complex [Cu(C(2)H(4)NC(2)H(4)NH(2)-N,N')(3)]Cl(2) (3b) or the bis-chelated complex [CuCl(C(2)H(2)Me(2)NC(2)H(2)Me(2)NH(2)-N,N')(2)]Cl (4c). By addition of 2H-3-phenylazirine (d) to PdCl(2), trans-[Cl(2)Pd(NCH(2)CPh)(2)] (5d) was formed. All new compounds were characterized by NMR, IR and mass spectra and also by X-ray structure analyses (except 3b). Additionally the cytotoxic effects of these complexes were examined on HL-60 and NALM-6 human leukemia cells and melanoma WM-115 cells. The antimicrobial activity was also determined. The growth of Gram-positive bacterial strains (S. aureus, S. epidermidis, E. faecalis) was inhibited by almost all tested complexes at the concentrations of 37.5-300.0 μg mL(-1). However, MIC values of complexes obtained for Gram-negative E. coli and P. aeruginosa, as well as for C. albicans yeast, mostly exceeded 300 μg mL(-1). The highest antibacterial activity was achieved by complexes 1a and 2b. Complex 2b also inhibited the growth of Gram-negative bacteria.

Reactions of Cu(I)Br with aziridine derivatives. Synthesis, characterization and crystal structures of monomeric, dimeric and hexameric aziridine (= az) complexes of the formal type [CuBr(az)2]n (n = 1, 2) and [CuBr(az)]6

The first syntheses of monomeric and oligomeric aziridine complexes of copper(I) are described. Cu(I)Br (1) reacts with a series of different aziridine derivatives (C(2)H(3)PhNH (2), C(2)H(2)Me(2)NH (3), C(2)H(2)Me(2)NC(2)H(2)Me(2)NH(2) (4)) to give the neutral dimeric complex [CuBr(C(2)H(3)PhNH)(2)](2) (5) and the ionic hexameric complex [Cu(6)Br(5)(C(2)H(2)Me(2)NH)(6)]Br (6) with terminal bound aziridine ligands as well as the neutral monomeric complex [CuBr(C(2)H(2)Me(2)NC(2)H(2)Me(2)NH(2))] (7) where the dimerized aziridine acts as a N,N'-chelating ligand. After purification, all of the complexes were fully characterized and their IR, (1)H and (13)C NMR spectra are reported and discussed. The single crystal structure analysis revealed distorted tetrahedral geometry for the copper(I) centres in the complexes 5 and 6 and a trigonal planar structure for complex 7. In the oligomers the copper centres are bridged by two μ(2)- (5) or two μ(3)- and three μ(4)-bromido ligands (6), respectively.